{"protocolSection":{"identificationModule":{"nctId":"NCT03280641","orgStudyIdInfo":{"id":"2015-P-016"},"organization":{"fullName":"Wuhan Asia Heart Hospital","class":"OTHER"},"briefTitle":"D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy","officialTitle":"The Role of D-dimer in Patients With Atrial Fibrillation Receiving Anticoagulation Therapy","acronym":"DIRECT"},"statusModule":{"statusVerifiedDate":"2017-09","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-08-09","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2017-07-30","type":"ACTUAL"},"completionDateStruct":{"date":"2017-09-01","type":"ACTUAL"},"studyFirstSubmitDate":"2017-09-10","studyFirstSubmitQcDate":"2017-09-10","studyFirstPostDateStruct":{"date":"2017-09-12","type":"ACTUAL"},"lastUpdateSubmitDate":"2017-09-10","lastUpdatePostDateStruct":{"date":"2017-09-12","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Wuhan Asia Heart Hospital","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This is a sigle-center, prospective study to evaluate the role of D-Dimer testing in patients with atrial fibrillation receiving Dabigatran or warfarin anticoagulation therapy.","detailedDescription":"Patients with atrial fibrillation receiving Dabigatran or warfarin anticoagulation therapy was screened and signed to two group: Dabigatran group and Warfarin group. D-dimer test was analyzed before and 3 months after anticoagulation starting specificly. Patients were followed-up for at least 12 months,and clinical outcomes, including thrombotic events major bleeding events and all-cause deaths were recorded during follow-up period."},"conditionsModule":{"conditions":["Atrial Fibrillation","Strokes Thrombotic"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":1194,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Dabigatran Group","description":"Patiets with atrial fibrillation received dabigatran (110mg, bid).","interventionNames":["Drug: Dabigatran Etexilate 110mg"]},{"label":"Warfarin Group","description":"Patiets with atrial fibrillation received warfarin (110mg, bid).The target international normalized ratio (INR):1.6-3.0","interventionNames":["Drug: Warfarin Sodium"]}],"interventions":[{"type":"DRUG","name":"Dabigatran Etexilate 110mg","description":"Dabigatran Etexilate 110mg, BID","armGroupLabels":["Dabigatran Group"],"otherNames":["Pradaxa"]},{"type":"DRUG","name":"Warfarin Sodium","description":"Target INR:1.6-3.0","armGroupLabels":["Warfarin Group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Cardiovascular events","description":"Thrombotic events, cardiovascular deaths, major bleeding events","timeFrame":"12 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Non-valvular atrial fibrillation\n* Receiving oral anticoagulation therapy and have good compliance\n\nExclusion Criteria:\n\n* Life expectancy less than 1 year\n* Thrombosis or major bleeding history within 3 months\n* Refusal to Participate","sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients with Non-valvular atrial fibrillation receiving Dabigatran or warfarin anticoagulation therapy.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Litao ZHANG, MD","affiliation":"Wuhan Asia Heart Hospital","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"WAHH","city":"Wuhan","state":"Hubei","zip":"430000","country":"China","geoPoint":{"lat":30.58333,"lon":114.26667}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED","description":"We will share the IPD after the paper being published"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083244","term":"Thrombotic Stroke"},{"id":"D000001281","term":"Atrial Fibrillation"}],"ancestors":[{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M2402","name":"Thrombotic Stroke","asFound":"Strokes Thrombotic","relevance":"HIGH"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000014859","term":"Warfarin"},{"id":"D000069604","term":"Dabigatran"}],"ancestors":[{"id":"D000000925","term":"Anticoagulants"},{"id":"D000000991","term":"Antithrombins"},{"id":"D000015842","term":"Serine Proteinase Inhibitors"},{"id":"D000011480","term":"Protease Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"}],"browseLeaves":[{"id":"M203805","name":"Fibrin fragment D","relevance":"LOW"},{"id":"M17292","name":"Warfarin","asFound":"Childhood lymphoblastic lymphoma","relevance":"HIGH"},{"id":"M490","name":"Dabigatran","asFound":"Embryo transfer","relevance":"HIGH"},{"id":"M3934","name":"Anticoagulants","relevance":"LOW"},{"id":"M3997","name":"Antithrombins","relevance":"LOW"},{"id":"M3996","name":"Antithrombin III","relevance":"LOW"},{"id":"M14033","name":"Protease Inhibitors","relevance":"LOW"},{"id":"M18081","name":"Serine Proteinase Inhibitors","relevance":"LOW"},{"id":"M19299","name":"HIV Protease Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"T18","name":"Serine","relevance":"LOW"}],"browseBranches":[{"abbrev":"Coag","name":"Coagulants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"AnCoag","name":"Anticoagulants"},{"abbrev":"Infe","name":"Anti-Infective Agents"},{"abbrev":"AA","name":"Amino Acids"}]}},"hasResults":false}